Recommendations on statistical approaches for pragmatic trials
This document provides guidance on choosing appropriate statistical methods for pragmatic clinical trials, which are studies that test treatments in real-world settings. It helps researchers ensure their analyses are valid and meaningful when applied to everyday clinical practice.
At a glance
Use when
Designing or analyzing pragmatic trials intended to inform health policy or clinical practice.
Avoid when
Conducting highly controlled explanatory trials with strict protocols and homogeneous populations.
Inputs
Data from pragmatic clinical trials, including baseline characteristics, treatment assignments, outcomes, and potential confounders.
Outputs
Statistically valid analyses that support generalizable conclusions about treatment effectiveness in routine care settings.
How it works
The guideline outlines statistical principles and methods tailored for pragmatic trials, emphasizing robust study design, appropriate handling of missing data, intention-to-treat analysis, and methods for dealing with heterogeneity of treatment effects. It supports valid inference in trials that prioritize generalizability over strict experimental control.
- Project
- GetReal
- Funding
- IMI
- Project status
- Completed 2021
- HTA domains
- Clinical Effectiveness
- Categories
- RWE
- Technology
- Non-specific
- Assumptions
- The trial design allows for real-world variability; data collection is sufficient to support robust statistical analysis; adherence to intention-to-treat principles is feasible.
- Strengths
- Enhances the credibility and applicability of pragmatic trial results; provides clear direction on complex statistical issues; supports regulatory and HTA acceptance of real-world evidence.
- Limitations
- May not address highly specialized or novel statistical techniques; assumes a certain level of statistical expertise among users.
Questions this answers
- › How should I analyze data from a pragmatic trial?
- › What statistical methods maintain validity in real-world settings?
- › How do I handle missing data in pragmatic trials?
- › Should I use intention-to-treat or per-protocol analysis?
- › How can I account for differences in patient response across settings?
- › What are best practices for statistical reporting in pragmatic trials?
Similar by meaning
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.